A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

Bibliographic Details
Main Authors:	Serrano, Davide, Lazzeroni, Matteo, Gandini, Sara, Macis, Debora, Johansson, Harriet, Gjerde, Jennifer, Lien, Ernst, Feroce, Irene, Pruneri, Giancarlo, Sandri, Maria Teresa, Bassi, Fabio, Brenelli, Fabricio, Luini, Alberto, Cazzaniga, Massimiliano, Varricchio, Clara, Guerrieri-Gonzaga, Aliana, DeCensi, Andrea, Bonanni, Bernardo
Format:	Online
Language:	English
Published:	BioMed Central 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053157/

id	pubmed-4053157
recordtype	oai_dc
spelling	pubmed-40531572014-06-12 A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer Serrano, Davide Lazzeroni, Matteo Gandini, Sara Macis, Debora Johansson, Harriet Gjerde, Jennifer Lien, Ernst Feroce, Irene Pruneri, Giancarlo Sandri, Maria Teresa Bassi, Fabio Brenelli, Fabricio Luini, Alberto Cazzaniga, Massimiliano Varricchio, Clara Guerrieri-Gonzaga, Aliana DeCensi, Andrea Bonanni, Bernardo Research Article BioMed Central 2013 2013-06-20 /pmc/articles/PMC4053157/ /pubmed/23786776 http://dx.doi.org/10.1186/bcr3439 Text en Copyright © 2013 Serrano et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Serrano, Davide Lazzeroni, Matteo Gandini, Sara Macis, Debora Johansson, Harriet Gjerde, Jennifer Lien, Ernst Feroce, Irene Pruneri, Giancarlo Sandri, Maria Teresa Bassi, Fabio Brenelli, Fabricio Luini, Alberto Cazzaniga, Massimiliano Varricchio, Clara Guerrieri-Gonzaga, Aliana DeCensi, Andrea Bonanni, Bernardo
spellingShingle	Serrano, Davide Lazzeroni, Matteo Gandini, Sara Macis, Debora Johansson, Harriet Gjerde, Jennifer Lien, Ernst Feroce, Irene Pruneri, Giancarlo Sandri, Maria Teresa Bassi, Fabio Brenelli, Fabricio Luini, Alberto Cazzaniga, Massimiliano Varricchio, Clara Guerrieri-Gonzaga, Aliana DeCensi, Andrea Bonanni, Bernardo A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer
author_facet	Serrano, Davide Lazzeroni, Matteo Gandini, Sara Macis, Debora Johansson, Harriet Gjerde, Jennifer Lien, Ernst Feroce, Irene Pruneri, Giancarlo Sandri, Maria Teresa Bassi, Fabio Brenelli, Fabricio Luini, Alberto Cazzaniga, Massimiliano Varricchio, Clara Guerrieri-Gonzaga, Aliana DeCensi, Andrea Bonanni, Bernardo
author_sort	Serrano, Davide
title	A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer
title_short	A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer
title_full	A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer
title_fullStr	A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer
title_full_unstemmed	A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer
title_sort	randomized phase ii presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer
description
publisher	BioMed Central
publishDate	2013
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053157/
_version_	1612099559148748800

A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

Similar Items